Edition:
United Kingdom

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

22.16USD
8:55pm GMT
Change (% chg)

$0.17 (+0.77%)
Prev Close
$21.99
Open
$22.17
Day's High
$22.36
Day's Low
$22.01
Volume
11,444
Avg. Vol
--
52-wk High
$25.30
52-wk Low
$21.94

Latest Key Developments (Source: Significant Developments)

Odonate Holdings Llc Reports A 11.5 Pct Stake In Odonate Therapeutics As Of Dec 6
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Odonate Holdings Llc ::Reports A 11.5 Pct Stake In Odonate Therapeutics Inc AS OF DEC 6 - SEC FILING.  Full Article

Boxer Capital LLC Reports 10.0 Pct Stake In Odonate Therapeutics As Of Dec 6
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Odonate Therapeutics Inc ::BOXER CAPITAL LLC REPORTS 10.0 PERCENT STAKE IN ODONATE THERAPEUTICS INC AS OF DECEMBER 6 - SEC FILING.BOXER CAPITAL LLC SAYS ACQUIRED POSITIONS IN ODONATE THERAPEUTICS INC'S COMMON STOCK FOR INVESTMENT PURPOSES.  Full Article

Odonate Therapeutics Shares Debut 4.2 Pct Below IPO Price
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - :ODONATE THERAPEUTICS SHARES OPEN AT $23.00 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $24.00/SHARE.  Full Article

Odonate Therapeutics Announces Pricing Of Initial Public Offering
Thursday, 7 Dec 2017 

Odonate Therapeutics Llc ::ODONATE THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.ODONATE THERAPEUTICS LLC- ‍ANNOUNCED PRICING OF ITS INITIAL PUBLIC OFFERING OF 6.25 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $24.00​.  Full Article

BRIEF-Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer

* ODONATE THERAPEUTICS ANNOUNCES INITIATION OF CONTESSA, A PHASE 3 STUDY OF TESETAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER Source text for Eikon: Further company coverage: